Ionis Pharmaceuticals (IONS) Intangibles (2010 - 2022)

Ionis Pharmaceuticals' Intangibles history runs 13 years deep, the most recent figure standing at $29.6 million for Q3 2022.

• In Q3 2022, Intangibles fell 1.44% year-over-year to $29.6 million; the TTM figure through Sep 2022 stood at $29.6 million (down 1.44% YoY), while the FY2021 annual figure was $29.0 million, up 3.82% from the prior year.
• Intangibles for Q3 2022 stood at $29.6 million, up from $29.1 million in the prior quarter.
• The five-year high for Intangibles was $30.0 million in Q3 2021, with the low at $22.9 million in Q1 2018.
• The 5-year median for Intangibles is $27.7 million (2020), against an average of $27.1 million.
• The sharpest annual moves came in 2019 and 2022: Intangibles increased 12.31% in 2019, then retreated 1.44% in 2022.
• Ionis Pharmaceuticals' Intangibles stood at $24.0 million in 2018, then advanced by 6.83% to $25.7 million in 2019, then climbed by 8.81% to $27.9 million in 2020, then increased by 3.82% to $29.0 million in 2021, then gained by 2.07% to $29.6 million in 2022.
• Business Quant data shows IONS's Intangibles at $29.6 million in Q3 2022, $29.1 million in Q2 2022, and $29.3 million in Q1 2022.